Developer docs
API playgroundTry for free, no card

Search company profiles

METUPUK

Full company profile

uuid004vy93

Namestring
METUPUK
Legal namestring
METUPUK (Metastatic Exchange To Unleash Power United Kingdom)
Websiteurl
metupuk.org.uk
Company typeenum
Private
Founded yearint
2016
Descriptiontext

METUPUK (Metastatic Exchange To Unleash Power United Kingdom) is a UK-registered patient advocacy charity (charity number 1196494) founded in 2016 by Jo Taylor, who established the UK chapter after meeting METUP founder Beth Caldwell in London. The organization is the only metastatic breast cancer (MBC)-specific patient advocacy group in the UK, and operates with no paid staff — five volunteer trustees, including Laura Ashurst (Chair, appointed January 2026), Emma Smith (Fundraising Trustee), Phil Southwell (Finance Trustee), Dr Helen Steele, Sue Thomas, and Kat Southwell, run all operations. METUPUK is entirely patient-led, with volunteers who are themselves living with MBC, providing advocacy grounded in direct lived experience of the disease.

The charity's core activities center on five advocacy priorities: earlier recognition of red flag symptoms to enable faster diagnosis; increased access to life-extending drugs and treatments; greater numbers of MBC-reflective clinical trials; improved data collection on MBC patients; and policy changes to keep MBC patient care a national priority. Notable outputs include the Red Flag Infographics (created via abcdiagnosis, signposted by NHS England for personalized care plans), the award-winning #DarkerPink campaign launched in 2021, a 2022 TV commercial that aired across 12 UK channels reaching almost 2 million people, and a 70,000+ signature parliamentary petition demanding change for MBC patients. Strategic partnerships include ABC Global Alliance (International Ally), Breast Cancer Now, Macmillan Cancer Support, Welsh Government and NHS Wales health boards, the Northern Ireland Cancer Charities Coalition (joined June 2024), and the National Audit of Metastatic Breast Cancer (NAoMe). METUPUK's technology footprint is minimal — the charity maintains a website, clinical trial database, and patient education infographics, but does not operate a software platform.

METUPUK's business model is donation-based, with no commercial products or services. Revenue derives from voluntary donations through the charity website and fundraising events (e.g., Nick's 310-mile bike ride through Wales), with no publicly disclosed financials. The organization has successfully influenced regulatory outcomes, including NICE and Scottish Medicines Consortium approval of Trodelvy for NHS use, and has helped secure clinical nurse specialist posts within NHS Foundation Trusts. The charity is also registered with the Office of the Scottish Charity Regulator (SCO55472) and operates regional groups including MBC Wales, with planned expansion to Scotland and Northern Ireland.

Short descriptiontext

METUPUK is the UK's only patient-led metastatic breast cancer advocacy charity, founded in 2016 and run entirely by unpaid volunteers. It campaigns for earlier diagnosis, drug access, more clinical trials, better data, and national policy priority for MBC patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNorthwold, Thetford, United Kingdom
HQ citystring
Northwold, Thetford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient advocacy services, metastatic breast cancer, cancer awareness education, charitable fundraising, healthcare policy advocacy
Industry3 codes
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYBPADAIAE
Health Systems Strengthening & Universal Health Coverage (UHC)
NAICS code2 codes
  • Individual and Family Services6241
  • Other Individual and Family Services624190
SIC code2 codes
  • Services-Social Services8300
  • Services-Health Services8000
Product category
Patient Advocacy Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Donations and Fundraising
TypeGrants Donations
Description

METUPUK relies on donations from supporters and fundraising activities. The charity received a £25,000 donation from Emma Smith and fundraising campaigns from supporters including Nick's 310-mile bike ride through Wales.

metupuk.org.uk
2Charitable Donations
TypeGrants Donations
Description

The charity accepts donations through its website with the stated purpose of using funds to achieve aims and objectives that make a real difference to people with metastatic breast cancer.

metupuk.org.uk
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Marketing or Sales, Operations, Technology or R&D, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

METUPUK is the UK's only patient advocacy charity dedicated to metastatic (secondary) breast cancer. It delivers free advocacy, awareness, and support services aimed at turning MBC into a chronic illness. Core activities include campaigning for drug access (e.g., Trodelvy approval via NICE/SMC), driving earlier recognition of red-flag symptoms through educational infographics, and providing patient-led community support across England, Wales, Scotland, and Northern Ireland.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Darker Pink TV campaign reached almost 2 million people across 12 TV channels including prime time Emmerdale slot
+2 more records
Product overview1 text field

METUPUK is a patient advocacy charity, not a commercial product company. It operates awareness campaigns (#DarkerPink, #IAmThe31), provides educational resources about metastatic breast cancer, advocates for drug access and clinical trials, offers patient support resources, and conducts advocacy work for policy changes. The organization does not offer commercial products or software services.

Product and service1 record
1Red Flag Infographics (#SBCinfographic)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

METUPUK is an International Ally of the ABC Global Alliance, a global coalition working to improve the lives of those living with advanced/metastatic breast cancer.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

METUPUK partnered with Breast Cancer Now for parliamentary petition hand-in with over 70,000 signatures. Breast Cancer Now launched the 'Unsurvivors' campaign that METUPUK supports.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Macmillan supports secondary breast cancer nurses in Wales health boards and provides welfare benefits support for MBC patients. METUPUK works with Macmillan on patient support initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

METUPUK works with Welsh Government, Welsh Cancer Network, and all health boards in Wales on the Metastatic Breast Cancer Pathway, secondary breast cancer nurse posts, and GP education programs.

5Northern Ireland Cancer Charities Coalition (NICCC)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

METUPUK joined the NICCC in June 2024 to work collaboratively with partner charities to improve outcomes for cancer patients in Northern Ireland.

metupuk.org.uk
Strategic tierMinorTypeOthers
Description

Hearts & Hope 4 Helen donated to METUPUK, with cheque handover at the Darker Pink exhibition in Glasgow.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

Break Creative Partners created and produced the Darker Pink 2022 TV commercial, supporting the campaign with creative services.

8NAoMe (National Audit of Metastatic Breast Cancer)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

METUPUK has been involved in the NAoMe project for the last year alongside other patient groups and stakeholders, working with NATCAN and Royal College of Surgeons of England.

metupuk.org.uk
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Prevent Breast Cancer
TypeRegional player
Description

A UK-based breast cancer charity focused on prediction and prevention research. While focused on primary prevention rather than metastatic disease, it operates in the same UK breast cancer charity ecosystem and addresses overlapping patient and policymaker audiences.

TypeBroad incumbent
Description

The world's largest independent cancer research charity. METUPUK Chair Laura Ashurst previously served as a Cancer Campaigns Ambassador for Cancer Research UK, indicating overlapping advocacy and patient-support missions despite Cancer Research UK's broader research focus.

TypeEmerging player
Description

A US-based nonprofit providing support and education for people impacted by breast cancer, with specific programs addressing metastatic disease. Comparable as a peer patient-support organization serving MBC patients with overlapping education and community-building activities.

4METAvivor
TypeDirect peer
Description

A US-based nonprofit dedicated specifically to metastatic breast cancer research, awareness, and patient support. Closely comparable mission focus on stage IV/metastatic breast cancer advocacy, drug access, and clinical trial awareness.

TypeBroad incumbent
Description

The world's largest breast cancer organization, addressing breast cancer across the continuum including metastatic disease. Comparable as a large incumbent breast cancer advocacy organization with overlapping awareness, research funding, and patient support activities.

TypeBroad incumbent
Description

The UK's leading cancer support charity providing welfare benefits support and secondary breast cancer nurses in Wales. METUPUK collaborates with Macmillan on patient support initiatives, making it a broad incumbent peer addressing overlapping patient populations.

TypeDirect peer
Description

The UK's largest breast cancer charity, with whom METUPUK partnered on the 70,000+ signature parliamentary petition hand-in and the 'Unsurvivors' campaign. Directly comparable mission focused on breast cancer patients in the UK with overlapping advocacy and policy goals.

TypeDirect peer
Description

A UK-based patient and family focused charity dedicated specifically to secondary (metastatic) breast cancer. Directly comparable niche focus on MBC patients with overlapping awareness, research funding, and patient support activities.

TypeDirect peer
Description

A global coalition working to improve the lives of those living with advanced/metastatic breast cancer. METUPUK is an International Ally, making it a direct peer in international MBC advocacy, treatment access, and policy alignment.

TypeDirect peer
Description

The original US-based metastatic breast cancer patient advocacy organization founded by Beth Caldwell. METUPUK was explicitly created as its UK chapter in 2016 after founder Jo Taylor met Beth Caldwell, making it the most direct peer in mission and structure.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

METUPUK

Patient Advocacy Servicesmetupuk.org.uk

METUPUK is the UK's only patient-led metastatic breast cancer advocacy charity, founded in 2016 and run entirely by unpaid volunteers. It campaigns for earlier diagnosis, drug access, more clinical trials, better data, and national policy priority for MBC patients.

What METUPUK does

METUPUK (Metastatic Exchange To Unleash Power United Kingdom) is a UK-registered patient advocacy charity (charity number 1196494) founded in 2016 by Jo Taylor, who established the UK chapter after meeting METUP founder Beth Caldwell in London. The organization is the only metastatic breast cancer (MBC)-specific patient advocacy group in the UK, and operates with no paid staff — five volunteer trustees, including Laura Ashurst (Chair, appointed January 2026), Emma Smith (Fundraising Trustee), Phil Southwell (Finance Trustee), Dr Helen Steele, Sue Thomas, and Kat Southwell, run all operations. METUPUK is entirely patient-led, with volunteers who are themselves living with MBC, providing advocacy grounded in direct lived experience of the disease.

The charity's core activities center on five advocacy priorities: earlier recognition of red flag symptoms to enable faster diagnosis; increased access to life-extending drugs and treatments; greater numbers of MBC-reflective clinical trials; improved data collection on MBC patients; and policy changes to keep MBC patient care a national priority. Notable outputs include the Red Flag Infographics (created via abcdiagnosis, signposted by NHS England for personalized care plans), the award-winning #DarkerPink campaign launched in 2021, a 2022 TV commercial that aired across 12 UK channels reaching almost 2 million people, and a 70,000+ signature parliamentary petition demanding change for MBC patients. Strategic partnerships include ABC Global Alliance (International Ally), Breast Cancer Now, Macmillan Cancer Support, Welsh Government and NHS Wales health boards, the Northern Ireland Cancer Charities Coalition (joined June 2024), and the National Audit of Metastatic Breast Cancer (NAoMe). METUPUK's technology footprint is minimal — the charity maintains a website, clinical trial database, and patient education infographics, but does not operate a software platform.

METUPUK's business model is donation-based, with no commercial products or services. Revenue derives from voluntary donations through the charity website and fundraising events (e.g., Nick's 310-mile bike ride through Wales), with no publicly disclosed financials. The organization has successfully influenced regulatory outcomes, including NICE and Scottish Medicines Consortium approval of Trodelvy for NHS use, and has helped secure clinical nurse specialist posts within NHS Foundation Trusts. The charity is also registered with the Office of the Scottish Charity Regulator (SCO55472) and operates regional groups including MBC Wales, with planned expansion to Scotland and Northern Ireland.

METUPUK firmographics

Firmographics
Name
METUPUK
Legal name
METUPUK (Metastatic Exchange To Unleash Power United Kingdom)
Website
https://metupuk.org.uk
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
METUPUK is the UK's only patient-led metastatic breast cancer advocacy charity, founded in 2016 and run entirely by unpaid volunteers. It campaigns for earlier diagnosis, drug access, more clinical trials, better data, and national policy priority for MBC patients.
Ownership category
akta.pro rank

METUPUK industry classification

Industry
Product category
Patient Advocacy Services
NAICS
Individual and Family Services (6241), Other Individual and Family Services (624190)
SIC
Services-Social Services (8300), Services-Health Services (8000)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYBPADAIAE
Health Systems Strengthening & Universal Health Coverage (UHC)

Keywords

  • Patient advocacy services
  • Metastatic breast cancer
  • Cancer awareness education
  • Charitable fundraising
  • Healthcare policy advocacy

Where METUPUK is headquartered

Location

Headquarters

HQ city
Northwold, Thetford
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

METUPUK business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Technology or R&D, Others

Revenue model

  1. Donations and Fundraising: METUPUK relies on donations from supporters and fundraising activities. The charity received a £25,000 donation from Emma Smith and fundraising campaigns from supporters including Nick's 310-mile bike ride through Wales.
  2. Charitable Donations: The charity accepts donations through its website with the stated purpose of using funds to achieve aims and objectives that make a real difference to people with metastatic breast cancer.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels9 records

METUPUK product offering

Product offering

Core offering

METUPUK is the UK's only patient advocacy charity dedicated to metastatic (secondary) breast cancer. It delivers free advocacy, awareness, and support services aimed at turning MBC into a chronic illness. Core activities include campaigning for drug access (e.g., Trodelvy approval via NICE/SMC), driving earlier recognition of red-flag symptoms through educational infographics, and providing patient-led community support across England, Wales, Scotland, and Northern Ireland.

Product overview

METUPUK is a patient advocacy charity, not a commercial product company. It operates awareness campaigns (#DarkerPink, #IAmThe31), provides educational resources about metastatic breast cancer, advocates for drug access and clinical trials, offers patient support resources, and conducts advocacy work for policy changes. The organization does not offer commercial products or software services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Red Flag Infographics (#SBCinfographic)

Quantifiable outcome

  • Darker Pink TV campaign reached almost 2 million people across 12 TV channels including prime time Emmerdale slot
  • +2 more outcomes

Companies that use METUPUK

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles2 records

METUPUK technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

METUPUK partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, major, minor and supporting.

  • ABC Global AlliancecoreStrategic or Co-development PartnerMETUPUK is an International Ally of the ABC Global Alliance, a global coalition working to improve the lives of those living with advanced/metastatic breast cancer.
  • Breast Cancer NowcoreStrategic or Co-development PartnerMETUPUK partnered with Breast Cancer Now for parliamentary petition hand-in with over 70,000 signatures. Breast Cancer Now launched the 'Unsurvivors' campaign that METUPUK supports.
  • Macmillan Cancer SupportmajorStrategic or Co-development PartnerMacmillan supports secondary breast cancer nurses in Wales health boards and provides welfare benefits support for MBC patients. METUPUK works with Macmillan on patient support initiatives.
  • Welsh Government and NHS Wales Health BoardscoreStrategic or Co-development PartnerMETUPUK works with Welsh Government, Welsh Cancer Network, and all health boards in Wales on the Metastatic Breast Cancer Pathway, secondary breast cancer nurse posts, and GP education programs.
  • Northern Ireland Cancer Charities Coalition (NICCC)majorStrategic or Co-development PartnerMETUPUK joined the NICCC in June 2024 to work collaboratively with partner charities to improve outcomes for cancer patients in Northern Ireland.
  • Hearts & Hope 4 HelenminorOthersHearts & Hope 4 Helen donated to METUPUK, with cheque handover at the Darker Pink exhibition in Glasgow.
  • Break Creative PartnerssupportingImplementation/ SI/ Consulting PartnerBreak Creative Partners created and produced the Darker Pink 2022 TV commercial, supporting the campaign with creative services.
  • NAoMe (National Audit of Metastatic Breast Cancer)coreStrategic or Co-development PartnerMETUPUK has been involved in the NAoMe project for the last year alongside other patient groups and stakeholders, working with NATCAN and Royal College of Surgeons of England.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

METUPUK competitors and assessment

Company assessment

Regional players

  • Prevent Breast Cancer: A UK-based breast cancer charity focused on prediction and prevention research. While focused on primary prevention rather than metastatic disease, it operates in the same UK breast cancer charity ecosystem and addresses overlapping patient and policymaker audiences.

Broad incumbents

  • Cancer Research UK: The world's largest independent cancer research charity. METUPUK Chair Laura Ashurst previously served as a Cancer Campaigns Ambassador for Cancer Research UK, indicating overlapping advocacy and patient-support missions despite Cancer Research UK's broader research focus.
  • Susan G. Komen: The world's largest breast cancer organization, addressing breast cancer across the continuum including metastatic disease. Comparable as a large incumbent breast cancer advocacy organization with overlapping awareness, research funding, and patient support activities.
  • Macmillan Cancer Support: The UK's leading cancer support charity providing welfare benefits support and secondary breast cancer nurses in Wales. METUPUK collaborates with Macmillan on patient support initiatives, making it a broad incumbent peer addressing overlapping patient populations.

Emerging players

  • Living Beyond Breast Cancer: A US-based nonprofit providing support and education for people impacted by breast cancer, with specific programs addressing metastatic disease. Comparable as a peer patient-support organization serving MBC patients with overlapping education and community-building activities.

Direct peers

  • METAvivor: A US-based nonprofit dedicated specifically to metastatic breast cancer research, awareness, and patient support. Closely comparable mission focus on stage IV/metastatic breast cancer advocacy, drug access, and clinical trial awareness.
  • Breast Cancer Now: The UK's largest breast cancer charity, with whom METUPUK partnered on the 70,000+ signature parliamentary petition hand-in and the 'Unsurvivors' campaign. Directly comparable mission focused on breast cancer patients in the UK with overlapping advocacy and policy goals.
  • Make 2nds Count: A UK-based patient and family focused charity dedicated specifically to secondary (metastatic) breast cancer. Directly comparable niche focus on MBC patients with overlapping awareness, research funding, and patient support activities.
  • ABC Global Alliance: A global coalition working to improve the lives of those living with advanced/metastatic breast cancer. METUPUK is an International Ally, making it a direct peer in international MBC advocacy, treatment access, and policy alignment.
  • METUP (US): The original US-based metastatic breast cancer patient advocacy organization founded by Beth Caldwell. METUPUK was explicitly created as its UK chapter in 2016 after founder Jo Taylor met Beth Caldwell, making it the most direct peer in mission and structure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

METUPUK social profiles

Digital presence

METUPUK financial estimates

Financial estimate

Revenue estimate

Valuation estimate

METUPUK leadership team

Management profile

Number of profiles

Profiles8 records

METUPUK funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

METUPUK M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about METUPUK

What does METUPUK do?

METUPUK is the UK's only patient advocacy charity dedicated to metastatic (secondary) breast cancer. It delivers free advocacy, awareness, and support services aimed at turning MBC into a chronic illness. Core activities include campaigning for drug access (e.g., Trodelvy approval via NICE/SMC), driving earlier recognition of red-flag symptoms through educational infographics, and providing patient-led community support across England, Wales, Scotland, and Northern Ireland.

Is METUPUK a public or private company?

METUPUK is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was METUPUK founded?

METUPUK was founded in 2016. It employs 1 to 10 people.

Where is METUPUK based?

METUPUK is headquartered in Northwold, Thetford, United Kingdom, in the Europe region.

How does METUPUK make money?

Two revenue lines are on record. Donations and Fundraising is the primary driver. The others are charitable Donations.

Who are METUPUK's main competitors?

Prevent Breast Cancer is listed as a regional player. Broad incumbents are Cancer Research UK, Susan G. Komen and Macmillan Cancer Support. Living Beyond Breast Cancer is listed as an emerging player. Direct peers are METAvivor, Breast Cancer Now, Make 2nds Count, ABC Global Alliance and METUP (US).

Does METUPUK have an API?

No public API is recorded for METUPUK.

What industry is METUPUK in?

METUPUK's product category is Patient Advocacy Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations. Its NAICS code is 6241 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales